675 related articles for article (PubMed ID: 10030284)
1. Prolonged allograft survival but no tolerance induction by modulating CD28 antibody JJ319 after high-responder rat heart transplantation.
Dengler TJ; Szabo G; Sido B; Nottmeyer W; Zimmerman R; Vahl CF; Hünig T; Meuer SC
Transplantation; 1999 Feb; 67(3):392-8. PubMed ID: 10030284
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival of rat to mouse cardiac xenografts with prolonged blockade of CD28-B7 interaction combined with peritransplant T-cell depletion.
Rehman A; Tu Y; Arima T; Linsley PS; Flye MW
Surgery; 1996 Aug; 120(2):205-12. PubMed ID: 8751584
[TBL] [Abstract][Full Text] [Related]
3. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
Woodward JE; Qin L; Chavin KD; Lin J; Tono T; Ding Y; Linsley PS; Bromberg JS; Baliga P
Transplantation; 1996 Oct; 62(7):1011-8. PubMed ID: 8878397
[TBL] [Abstract][Full Text] [Related]
4. CD4-targeted therapy and CD28-B7 costimulatory blockage may independently induce tolerance in sensitized allograft recipients.
Kato H; Onodera K; Chandraker A; Volk HD; Sayegh MH; Kupiec-Weglinski JW
Transplant Proc; 1998 Jun; 30(4):1063-4. PubMed ID: 9636430
[No Abstract] [Full Text] [Related]
5. Mechanisms of targeting CD28 by a signaling monoclonal antibody in acute and chronic allograft rejection.
Dong VM; Yuan X; Coito AJ; Waaga AM; Sayegh MH; Chandraker A
Transplantation; 2002 Apr; 73(8):1310-7. PubMed ID: 11981427
[TBL] [Abstract][Full Text] [Related]
6. Blockade of the B7-CD28 pathway by CTLA4-Ig counteracts rejection and prolongs survival in small bowel transplantation.
Kurlberg G; Haglind E; Schön K; Törnqvist H; Lycke N
Scand J Immunol; 2000 Mar; 51(3):224-30. PubMed ID: 10736090
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28.
Lin H; Rathmell JC; Gray GS; Thompson CB; Leiden JM; Alegre ML
J Exp Med; 1998 Jul; 188(1):199-204. PubMed ID: 9653096
[TBL] [Abstract][Full Text] [Related]
8. Preventing allograft rejection with CTLA4IG: effect of donor-specific transfusion route or timing.
Bolling SF; Lin H; Wei RQ; Turka LA
J Heart Lung Transplant; 1996 Sep; 15(9):928-35. PubMed ID: 8889989
[TBL] [Abstract][Full Text] [Related]
9. Comparative strategies to induce long-term graft acceptance in fully allogeneic renal versus cardiac allograft models by CD28-B7 T cell costimulatory blockade: role of thymus and spleen.
Schaub M; Stadlbauer TH; Chandraker A; Vella JP; Turka LA; Sayegh MH
J Am Soc Nephrol; 1998 May; 9(5):891-8. PubMed ID: 9596088
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK
Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031
[TBL] [Abstract][Full Text] [Related]
11. CD28-B7 T-cell co-stimulatory blockade potentiates the effects of intrathymic immunomodulation in sensitized graft recipients.
Stadlbauer TH; Schaub M; Korom S; Onodera K; Sayegh MH; Kupiec-Weglinski JW
Transplantation; 1997 Dec; 64(12):1816-22. PubMed ID: 9422425
[TBL] [Abstract][Full Text] [Related]
12. Distinct tolerance pathways in sensitized allograft recipients after selective blockade of activation signal 1 or signal 2.
Onodera K; Chandraker A; Volk HD; Ritter T; Lehmann M; Kato H; Sayegh MH; Kupiec-Weglinski JW
Transplantation; 1999 Jul; 68(2):288-93. PubMed ID: 10440403
[TBL] [Abstract][Full Text] [Related]
13. CD28 blockade alters cytokine mRNA profiles in cardiac transplantation.
Lin H; Wei RQ; Goodman RE; Bolling SF
Surgery; 1997 Aug; 122(2):129-37. PubMed ID: 9288115
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of CD28 versus B7 blockade on direct pathway of allorecognition and self-restricted responses.
Haspot F; Villemain F; Laflamme G; Coulon F; Olive D; Tiollier J; Soulillou JP; Vanhove B
Blood; 2002 Mar; 99(6):2228-34. PubMed ID: 11877302
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD40 therapy extends renal allograft survival in rhesus macaques.
Pearson TC; Trambley J; Odom K; Anderson DC; Cowan S; Bray R; Lin A; Hollenbaugh D; Aruffo A; Siadak AW; Strobert E; Hennigar R; Larsen CP
Transplantation; 2002 Oct; 74(7):933-40. PubMed ID: 12394833
[TBL] [Abstract][Full Text] [Related]
16. The time course of CTLAIg effect on cardiac allograft rejection.
Bolling SF; Lin H; Turka LA
J Surg Res; 1996 Jun; 63(1):320-3. PubMed ID: 8661218
[TBL] [Abstract][Full Text] [Related]
17. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression.
Guillot C; Mathieu P; Coathalem H; Le Mauff B; Castro MG; Tesson L; Usal C; Laumonier T; Brouard S; Soulillou JP; Lowenstein PR; Cuturi MC; Anegon I
J Immunol; 2000 May; 164(10):5258-68. PubMed ID: 10799887
[TBL] [Abstract][Full Text] [Related]
18. CD28-B7 T cell costimulatory blockade by CTLA4Ig in the rat renal allograft model: inhibition of cell-mediated and humoral immune responses in vivo.
Akalin E; Chandraker A; Russell ME; Turka LA; Hancock WW; Sayegh MH
Transplantation; 1996 Dec; 62(12):1942-5. PubMed ID: 8990393
[TBL] [Abstract][Full Text] [Related]
19. Transplantation tolerance induced by CTLA4-Ig.
Pearson TC; Alexander DZ; Winn KJ; Linsley PS; Lowry RP; Larsen CP
Transplantation; 1994 Jun; 57(12):1701-6. PubMed ID: 8016872
[TBL] [Abstract][Full Text] [Related]
20. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism.
Pearson TC; Alexander DZ; Hendrix R; Elwood ET; Linsley PS; Winn KJ; Larsen CP
Transplantation; 1996 Apr; 61(7):997-1004. PubMed ID: 8623206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]